What is he best known for?
The fields of study he is best known for:
- Gene
- Immune system
- Cancer
His primary areas of investigation include Immunology, T cell, Indoleamine 2,3-dioxygenase, Cell biology and Immune tolerance.
His work in the fields of Immunology, such as Immune system, Antigen, Immunotherapy and Adoptive cell transfer, overlaps with other areas such as Population.
His studies deal with areas such as In vitro, CD8 and Major histocompatibility complex as well as T cell.
His study in Indoleamine 2,3-dioxygenase is interdisciplinary in nature, drawing from both Acquired immune system, Cancer research, Dendritic cell, Immunosuppression and Dioxygenase.
His Cell biology research includes elements of CD28, Biochemistry and Macrophage.
His research in Immune tolerance intersects with topics in Cellular immunity and Sirolimus.
His most cited work include:
- Prevention of allogeneic fetal rejection by tryptophan catabolism (2134 citations)
- IDO expression by dendritic cells: tolerance and tryptophan catabolism. (1826 citations)
- INHIBITION OF T CELL PROLIFERATION BY MACROPHAGE TRYPTOPHAN CATABOLISM (1256 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Immunology, T cell, Immune system, Indoleamine 2,3-dioxygenase and Cytotoxic T cell.
His study on Immunology is mostly dedicated to connecting different topics, such as Cell biology.
His T cell study integrates concerns from other disciplines, such as Tryptophan, T lymphocyte, Signal transduction and Transplantation.
His Indoleamine 2,3-dioxygenase research incorporates themes from Dendritic cell, CD19, Graft-versus-host disease and Immunosuppression.
His study focuses on the intersection of Cytotoxic T cell and fields such as Molecular biology with connections in the field of Gene, Genetically modified mouse, T-cell receptor, Transgene and Clonal deletion.
His research investigates the connection between Immune tolerance and topics such as Immunotherapy that intersect with problems in Cancer research.
He most often published in these fields:
- Immunology (57.61%)
- T cell (31.69%)
- Immune system (27.98%)
What were the highlights of his more recent work (between 2013-2021)?
- Immunology (57.61%)
- Immune system (27.98%)
- Cancer research (15.23%)
In recent papers he was focusing on the following fields of study:
Andrew L. Mellor mainly investigates Immunology, Immune system, Cancer research, T cell and Autoimmunity.
His Immunology study frequently draws connections between adjacent fields such as Indoleamine 2,3-dioxygenase.
His Immune system research is multidisciplinary, incorporating elements of Receptor, Pharmacology, Cell growth and Cell biology.
His studies in Cancer research integrate themes in fields like Immune checkpoint, Adoptive immunotherapy, Melphalan, Tumor microenvironment and Regulatory T cell.
The concepts of his T cell study are interwoven with issues in Acquired immune system, Cytokine, Function, Cell therapy and Myelin oligodendrocyte glycoprotein.
His Autoimmunity research integrates issues from Arthritis, Stimulator of interferon genes, DNA, Systemic lupus erythematosus and Interferon type I.
Between 2013 and 2021, his most popular works were:
- IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance (414 citations)
- IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation (128 citations)
- STING Promotes the Growth of Tumors Characterized by Low Antigenicity via IDO Activation (112 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Immune system
- Cancer
Andrew L. Mellor spends much of his time researching Immunology, Immune system, Immunotherapy, T cell and Cell biology.
His Immunology study combines topics from a wide range of disciplines, such as Carcinogenesis and Radiation therapy.
His work carried out in the field of Immune system brings together such families of science as Receptor, Cancer research and Indoleamine 2,3-dioxygenase.
His Indoleamine 2,3-dioxygenase research is multidisciplinary, relying on both Tensin and PTEN.
His T cell research focuses on subjects like Acquired immune system, which are linked to Endocrinology and Internal medicine.
His biological study spans a wide range of topics, including Interleukin 3, Cellular differentiation, Inflammation, Proinflammatory cytokine and Apoptosis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
